对于结核病或急性呼吸道感染的维生素D:在翻译中丢失了吗?
1Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
Current opinion in infectious diseases
|January 19, 2026
概括
维生素D补充剂不能预防急性呼吸道感染 (ARI) 或结核病. 最近的试验显示,预防或治疗这些疾病没有好处,与早期的发现形成对比.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 传染性疾病 传染性疾病
- 营养科学 营养科学
背景情况:
- 实验室和早期研究表明,维生素D可以预防或治疗结核病和急性呼吸道感染 (ARI).
- 观察数据和初步试验表明补充维生素D的潜在益处.
研究的目的:
- 审查3期随机对照试验 (RCT) 和对结核病和ARI的维生素D的元分析.
- 调和积极的早期发现和最近的负面试验结果之间的差异.
主要方法:
- 对最近的第三阶段RCT和元分析进行系统审查.
- 分析导致不同类型研究结果对比的因素.
主要成果:
- 目前来自RCT和元分析的证据不支持维生素D用于预防ARI或结核病.
- 补充维生素D并不能改善结核病治疗的反应.
结论:
- 积极的早期发现可能是由于有限的生理学相关性,非因果关系和偏见.
- 第三阶段RCT的限制,包括参与者选择和剂量,可能会掩盖潜在的益处.
相关概念视频
16:56Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
17.5K
The present work illustrates the convenience of using sublingual immunotherapy to boost the innate immune response in the lungs and confer protection against acute pneumococcal pneumonia in...
17.5K
09:23Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
12.5K
Galleria mellonella was recently established as a reproducible, cheap, and ethically acceptable infection model for the Mycobacterium tuberculosis complex. Here we describe and demonstrate the steps taken to establish successful infection of G. mellonella with bioluminescent Mycobacterium bovis BCG...
12.5K
05:14An Assay to Evaluate Drug Efficacy against a Mycobacterium tuberculosis Infection Model
566
This video demonstrates an assay to evaluate the efficacy of drugs against Mycobacterium tuberculosis (Mtb) infection. An in vitro infection model containing Mtb/macrophage aggregates is generated that mimics in vivo infection. Upon introducing suitable antibiotics, their efficacy is tested via resuzarin assay to monitor the survival of bacteria with increasing drug...
566
01:21Acute Respiratory Failure-I
883
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
883
01:21Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
01:29Acute Respiratory Failure-V
470
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
470